$4.74
0.194.18%
At Close: -
$4.64
-0.1-2.11%
After Hours: 7:12 PM EDT
15 minutes delayed
Lipocine reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Lipocine using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $-0.56 | $-0.78 | 28.2 % |
Mar 2024 | 2024-05-09 | $0.66 | $-0.68 | 197.1 % |
Dec 2023 | 2024-03-07 | $-0.42 | $-0.47 | 10.6 % |
Jun 2023 | 2023-08-10 | $-0.68 | $-0.64 | -6.25 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $89.57K | $290.00K | -69.1 % |
Sep 2023 | 2023-11-08 | $-3.12M | $470.00K | -764.3 % |
Jun 2023 | 2023-08-10 | $0 | $280.00K | -100.0 % |
Mar 2023 | 2023-05-11 | $54.99K | $780.00K | -93.0 % |
Lipocine (LPCN) is scheduled to report earnings on November 6, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $-0.56, which beat the estimate of $-0.78.
The Actual Revenue was $89.6K, which missed the estimate of $290K.
Browse earnings estimates, EPS, and revenue on all stocks.